NCT02642965
Clinical Trial Information
Trial Number: NCT02642965 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone Followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children with Relapsed Acute Myeloid Leukemia (AML)
Study ID:
AAML1421
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02642965-D1 | NCT02642965-D1 Dataset There is 1 dataset associated with PMID 32401633, NCT02642965-D1. The NCT02642965-D1 dataset is a patient level dataset (single row per patient) containing patient characteristics, response, toxicity, and outcome for eligible pediatric acute myeloid leukemia (AML) patients enrolled on the AAML1421 clinical trial. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®